Multiscale Model Identifies Improved Schedule for Treatment of Acute Myeloid Leukemia In Vitro With the Mcl‐1 Inhibitor AZD5991-Reference-Cited by-同舟云学术

Multiscale Model Identifies Improved Schedule for Treatment of Acute Myeloid Leukemia In Vitro With the Mcl‐1 Inhibitor AZD5991

Published:2020-09-17 Issue:10 Volume:9 Page:561-570
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Goliaei Ardeshir¹²,Woods Haley A.³,Tron Adriana E.³⁴,Belmonte Matthew A.³,Secrist J. Paul³,Ferguson Douglas¹,Drew Lisa³,Fretland Adrian J.¹,Aldridge Bree B.⁵⁶,Gibbons Francis D.¹

Affiliation:

1. Drug Metabolism and Pharmacokinetics (DMPK) Oncology R&D AstraZeneca Waltham Massachusetts USA

2. Novartis Institutes for Biomedical Research Cambridge Massachusetts USA

3. Bioscience Oncology R&D AstraZeneca Waltham Massachusetts USA

4. Agios Pharmaceuticals Cambridge Massachusetts USA

5. Department of Molecular Biology and Microbiology Tufts University School of Medicine Boston Massachusetts USA

6. Department of Biomedical Engineering Tufts University Medford Massachusetts USA

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12552

Reference41 articles.

1. Hallmarks of Cancer: The Next Generation

2. The Hallmarks of Cancer

3. Apoptosis: A Review of Programmed Cell Death

4. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

5. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative systems pharmacology modeling of tumor heterogeneity in response to BH3‐mimetics using virtual tumors calibrated with cell viability assays;CPT: Pharmacometrics & Systems Pharmacology;2024-05-15

2. A PKPD Case Study: Achieving Clinically Relevant Exposures of AZD5991 in Oncology Mouse Models;The AAPS Journal;2023-06-28

3. Programmed cell death, redox imbalance, and cancer therapeutics;Apoptosis;2021-07-08